AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Dec 17, 2019 424B5 PROSPECTUS SUPPLEMENTAL AMENDMENT
UPLOAD Nov 25, 2019
10-Q Nov 14, 2019 FORM 10-Q QUARTERLY REPORT
10-K/A Oct 30, 2019 FORM 10-K/A AMENDED ANNUAL REPORT
CORRESP Oct 29, 2019
UPLOAD Oct 23, 2019
10-Q Aug 14, 2019 FORM 10-Q QUARTERLY REPORT
8-K Jul 9, 2019 FORM 8K CURRENT REPORT
8-K Jun 4, 2019 FORM 8K CURRENT REPORT
10-Q May 15, 2019 FORM 10-Q QUARTERLY REPORT
8-K Apr 23, 2019 FORM 8K CURRENT REPORT
10-K Apr 8, 2019 FORM 10-K ANNUAL REPORT
8-K Apr 4, 2019 FORM 8-K CURRENT REPORT
NT 10-K Apr 1, 2019 FORM NT 10-K NOTICE OF LATE FILING
8-K Feb 26, 2019 FORM 8-K CURRENT REPORT
8-K Jan 15, 2019 FORM 8-K CURRENT REPORT
8-K Jan 8, 2019 FORM 8-K CURRENT REPORT
8-K Dec 7, 2018 FORM 8-K CURRENT REPORT
10-Q Nov 14, 2018 FORM 10-Q QUARTERLY REPORT
8-K Sep 13, 2018 FORM 8-K CURRENT REPORT
8-K Aug 27, 2018 FORM 8-K CURRENT REPORT
10-Q/A Aug 17, 2018 FORM 10-Q/A AMENDED QUARTERLY REPORT
10-Q Aug 14, 2018 FORM 10-Q QUARTERLY REPORT
D May 21, 2018
10-Q/A May 18, 2018 FORM 10-Q/A AMENDED QUARTERLY REPORT
← Newer Page 6 of 13 · 306 filings Older →